This is an old revision of the document!
Ocular Complications from Chemotherapeutic Agents
MEK inhibitors
- Selumetinib
- Blurred vision, diplopia, eyelid edema, subconjunctival hemorrhage, increased lacrimation, retinal pigment and epithelial detachment